Literature DB >> 9626226

Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.

G B Wisman1, H Hollema, S de Jong, J ter Schegget, S P Tjong-A-Hung, M H Ruiters, M Krans, E G de Vries, A G van der Zee.   

Abstract

PURPOSE: To evaluate the diagnostic value of semi-quantitative telomerase activity assessment in cervical scrapings together with human papillomavirus (HPV) typing for detection of (pre)neoplastic cervical lesions and to compare telomerase activity in cervical scrapings and frozen specimens from the same patients. PATIENTS AND METHODS: A cross-sectional study was performed in 161 patients referred for an abnormal cervical cytology report. In cervical scrapings, telomerase activity was determined by modified telomere repeat amplification protocol (TRAP) assay and HPV typing by polymerase chain reaction (PCR) with general and type-specific primers. Final diagnosis was made by pathologic examination of biopsy and/or loop excision specimens.
RESULTS: Telomerase activity was detectable in assessable scrapings from one of nine (11%) patients without cervical intraepitheleal neoplasia (CIN), in three of 26 (12%) with CIN I, eight of 35 (22%) with CIN II, 18 of 62 (29%) with CIN III, and four of 13 (31%) with cancer. Sensitivity and negative predictive value of the TRAP assay for CIN II/III and cancer lesions were 25% and 28%, respectively, while specificity for no CIN or CIN I was 89%. In representative frozen sections, frequency of detectable telomerase activity was related to grade of CIN/cancer; none of 21 normal cervices, none of two CIN I, two of 12 (17%) CIN II, 10 of 31 (32%) CIN III, and 18 of 21 (86%) cervical cancer lesions were telomerase-positive (P < .0005). Telomerase activity levels in paired scrapings and frozen sections appeared to be only weakly related; telomerase-positive sections with negative scrapings and vice versa (only in CIN III) were observed. In oncogenic HPV-negative scrapings (n = 14), no telomerase activity was detected, but in frozen sections, telomerase activity levels appeared to be unrelated to presence of specific HPV types.
CONCLUSION: Telomerase activity is more frequent in higher grade CIN/cervical cancer lesions. Telomerase activity assessment in cervical scrapings has a low sensitivity for CIN II/III and/or cervical cancer and does not appear to be useful in primary screening for cervical cancer. However, increased telomerase activity in frozen CIN sections may be a possible marker of progressive disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626226     DOI: 10.1200/JCO.1998.16.6.2238

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  14 in total

1.  Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.

Authors:  P L Cheah; L M Looi; M H Ng; V Sivanesaratnam
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

2.  Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population.

Authors:  R C Sobti; J Kochar; K Singh; D Bhasin; N Capalash
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

3.  Potential of telomerase expression and activity in cervical specimens as a diagnostic tool.

Authors:  S Bravaccini; M A Sanchini; A Amadori; L Medri; L Saragoni; D Calistri; F Monti; A Volpi; D Amadori
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

4.  Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.

Authors:  Zhong-Ying Shen; Li-Yan Xu; En-Min Li; Wei-Jia Cai; Min-Hua Chen; Jian Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

5.  Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity.

Authors:  Astrid C Baege; Allison Berger; Robert Schlegel; Tim Veldman; Richard Schlegel
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears.

Authors:  Kevin A Ault; Heather K Allen; Stacia L Phillips; M Bridget Zimmerman; Aloysius J Klingelhutz
Journal:  J Low Genit Tract Dis       Date:  2005-04       Impact factor: 1.925

7.  Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.

Authors:  Ni Sima; Liping Cai; Yuanfang Zhu; Wei Wang; Shixuan Wang; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

8.  hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.

Authors:  Jillian de Wilde; Jan M Kooter; Renée M Overmeer; Debbie Claassen-Kramer; Chris J L M Meijer; Peter J F Snijders; Renske D M Steenbergen
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

9.  Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.

Authors:  N Reesink-Peters; M N Helder; G B A Wisman; A J Knol; S Koopmans; H M Boezen; E Schuuring; H Hollema; E G E de Vries; S de Jong; A G J van der Zee
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

10.  The status of telomerase enzyme activity in benign and malignant gynaecologic pathologies.

Authors:  Ilhami Gül; Ozgür Dündar; Serkan Bodur; Yusuf Tunca; Levent Tütüncü
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.